Wells Fargo’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $522K | Buy |
|
|||||
|
2025
Q1 | $479K | Sell |
|
|||||
|
2024
Q4 | $591K | Sell |
|
|||||
|
2024
Q3 | $1.18M | Buy |
|
|||||
|
2024
Q2 | $532K | Sell |
|
|||||
|
2024
Q1 | $712K | Buy |
|
|||||
|
2023
Q4 | $338K | Sell |
|
|||||
|
2023
Q3 | $252K | Sell |
|
|||||
|
2023
Q2 | $435K | Buy |
|
|||||
|
2023
Q1 | $364K | Buy |
|
|||||
|
2022
Q4 | $79.8K | Sell |
|
|||||
|
2022
Q3 | $72K | Sell |
|
|||||
|
2022
Q2 | $84K | Sell |
|
|||||
|
2022
Q1 | $1.47M | Sell |
|
|||||
|
2021
Q4 | $1.72M | Sell |
|
|||||
|
2021
Q3 | $2.63M | Buy |
|
|||||
|
2021
Q2 | $3M | Sell |
|
|||||
|
2021
Q1 | $3.38M | Buy |
|
|||||
|
2020
Q4 | $2.2M | Buy |
|
|||||
|
2020
Q3 | $2.14M | Buy |
|
|||||
|
2020
Q2 | $1.56M | Buy |
|
|||||
|
2020
Q1 | $1.24M | Buy |
|
|||||
|
2019
Q4 | $1.3M | Buy |
|
|||||
|
2019
Q3 | $659K | Buy |
|
|||||
|
2019
Q2 | $679K | Sell |
|
|||||
|
2019
Q1 | $927K | Sell |
|
|||||
|
2018
Q4 | $1.38M | Buy |
|
|||||
|
2018
Q3 | $739K | Buy |
|
|||||
|
2018
Q2 | $416K | Sell |
|
|||||
|
2018
Q1 | $470K | Sell |
|
|||||
|
2017
Q4 | $642K | Sell |
|
|||||
|
2017
Q3 | $475K | Buy |
|
|||||
|
2017
Q2 | $502K | Sell |
|
|||||
|
2017
Q1 | $873K | Buy |
|
|||||
|
2016
Q4 | $268K | Buy |
|
|||||
|
2016
Q3 | $171K | Buy |
|
|||||
|
2016
Q2 | $24K | Sell |
|
|||||
|
2016
Q1 | $125K | Buy |
|
|||||
|
2015
Q4 | $157K | Buy |
|
|||||
|
2015
Q3 | $1K | Sell |
|
|||||
|
2015
Q2 | $6K | Buy |
|